Liver Illness and Psoriatic Patients
Psoriasis is a chronic inflammatory disease of the skin affecting approximately 2% of the world’s population. Systemic treatments, including methotrexate and cyclosporin, are associated with potential hepatotoxicity, due to either direct liver damage or immunosuppression or both immunomediated and a...
Main Authors: | Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/3140983 |
Similar Items
-
Differences in Osteoimmunological Biomarkers Predictive of Psoriatic Arthritis among a Large Italian Cohort of Psoriatic Patients
by: Marco Diani, et al.
Published: (2019-11-01) -
Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives
by: Fiore M, et al.
Published: (2017-10-01) -
Lipid profile disturbances may predispose psoriatic patients to liver dysfunction
by: Dorota Kozłowska, et al.
Published: (2021-05-01) -
THE FREQUENCY OF PSORIATIC ARTHRITIS IN PSORIATIC PATIENTS IN SULAIMANIA CITY
by: Raof R. Mirza, et al.
Published: (2011-12-01) -
The Study of Results of Liver Biopsy in Psoriatic Patients Which Treated by Methotrexate
by: Shora Manighalam, et al.
Published: (1996-03-01)